ArticleAntibiotics (Basel, Switzerland)2021
Assessing the Impact of COVID-19 on Antimicrobial Stewardship Activities/Programs in the United Kingdom.
Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
56 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- A systematic review of national interventions and policies to optimize antibiotic use in healthcare settings in England.The Journal of antimicrobial chemotherapy · 2024Pooled it
- Antimicrobial stewardship implementation before and during the COVID-19 pandemic in the acute care settings: a systematic review.BMC public health · 2023Pooled it
- National Antimicrobial Stewardship Performance and Antimicrobial Use in Saudi Ministry of Health Hospitals: A Four-Year Multicenter Surveillance Analysis, 2021-2024.Antibiotics (Basel, Switzerland) · 2026Article
- Optimizing antimicrobial stewardship during operational upheaval: lessons in resiliency from the COVID-19 pandemic.Infection control and hospital epidemiology · 2026Article
- Effectiveness and safety of a prospective audit and feedback-based antimicrobial stewardship program in hospitalized COVID-19 patients: a quasi-experimental before-and-after study.Frontiers in pharmacology · 2026Article
- Article
- The Impact of COVID-19 on the Epidemiology of Carbapenem Resistance.Antibiotics (Basel, Switzerland) · 2025Review
- Antifungal stewardship in the UK: where are we now?JAC-antimicrobial resistance · 2025Article
- Trends in inpatient antibiotic use in Indonesia and the Philippines during the COVID-19 pandemic.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025Article
- A Six Years' Trend Analysis of Antimicrobial Resistance Among Bacterial Isolates at Public Health Institute in Amhara Region, Ethiopia.BioMed research international · 2025Article
- Impact of a multifaceted antibiotic stewardship programme in a paediatric acute care unit over 8 years.JAC-antimicrobial resistance · 2024Article
- The impact of the COVID-19 pandemic on the antimicrobial stewardship workforce in Scottish acute care hospitals-a qualitative study.JAC-antimicrobial resistance · 2024Article
- The Impact of an Antimicrobial Stewardship Program on Days of Therapy in the Pediatric Center: An Interrupted Time-Series Analysis of a 19-Year Study.Journal of Korean medical science · 2024Article
- Tracking progress on antimicrobial resistance by the quadripartite country self-assessment survey (TrACSS) in G7 countries, 2017-2023: opportunities and gaps.Pharmacological research · 2024Review
- Time is running out. No excuses to delay implementation of antimicrobial stewardship programmes: impact, sustainability, resilience and efficiency through an interrupted time series analysis (2017-2022).JAC-antimicrobial resistance · 2024Article
- COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance.The Journal of antimicrobial chemotherapy · 2023Article
- Article
- Overprescription of antibiotics for treating hospitalized COVID-19 patients: A systematic review & meta-analysis.Heliyon · 2023Article
- Impact of the COVID-19 pandemic on antimicrobial stewardship support for general practices in England: a qualitative interview study.BJGP open · 2023Article
- Antibiotic utilisation and resistance over the first decade of nationally funded antimicrobial stewardship programmes in Singapore acute-care hospitals.Antimicrobial resistance and infection control · 2023Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since first identified in late 2019, the acute respiratory syndrome coronavirus (SARS-CoV2) and the resulting coronavirus disease (COVID-19) pandemic has overwhelmed healthcare systems worldwide, often diverting key resources in a bid to meet unprecedented challenges. To measure its impact on national antimicrobial stewardship (AMS) activities, a questionnaire was designed and disseminated to antimicrobialstewardship leads in the United Kingdom (UK). Most respondents reported a reduction in AMS activity with 64% (61/95) reporting that COVID-19 had a negative impact on routine AMS activities. Activities reported to have been negatively affected by the pandemic include audit, quality improvement initiatives, education, AMS meetings, and multidisciplinary working including ward rounds. However, positive outcomes were also identified, with technology being increasingly used as a tool to facilitate stewardship e.g., virtual meetings and ward rounds and increased the acceptance of using procalcitonin tests to distinguish between viral and bacterial infections. The COVID-19 pandemic has had a significant impact on the AMS activities undertaken across the UK. The long-term impact of the reduced AMS activities on incidence of AMR are not yet known. The legacy of innovation, use of technology, and increased collaboration from the pandemic could strengthen AMS in the post-pandemic era and presents opportunities for further development of AMS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.